Cite
HARVARD Citation
Bartels, S. et al. (2021). Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression. European journal of haematology. pp. 520-528. [Online].